Skip to main
USPH

USPH Stock Forecast & Price Target

USPH Analyst Ratings

Based on 3 analyst ratings
Buy
Strong Buy 0%
Buy 100%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

US Physical Therapy Inc. demonstrates positive financial growth as evidenced by a sequential commercial pricing increase of 2.2%, which signals strong demand for its services. The company's Industrial Injury Prevention (IIP) revenue experienced a notable growth of 22.2%, with an 18.4% increase when excluding acquisitions, highlighting its operational strength and market positioning. Additionally, the successful integration of the recently acquired Metro business is reflected in the increased net rate, rising from approximately $101 to $107.50, further enhancing the firm's revenue potential.

Bears say

US Physical Therapy's recent financial metrics show a decline of 0.6% in its key revenue figure, positioning it at $83.95 compared to $84.46 in the same period last year. The company has been experiencing ongoing reimbursement cuts for five consecutive years, cumulatively impacting profitability by approximately $20 million, which adds significant pressure to their financial stability. Additionally, operational expenses, particularly rent and clinic-related costs, were slightly higher than anticipated at 20.2% of revenue, suggesting potential challenges in managing operational efficiency amid a constricting revenue environment.

USPH has been analyzed by 3 analysts, with a consensus rating of Buy. 0% of analysts recommend a Strong Buy, 100% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of U.S. Physical Therapy and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About U.S. Physical Therapy (USPH) Forecast

Analysts have given USPH a Buy based on their latest research and market trends.

According to 3 analysts, USPH has a Buy consensus rating as of Jan 13, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $105.33, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $105.33, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

U.S. Physical Therapy (USPH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.